Immune reconstitution syndrome associated with opportunistic mycoses

Lancet Infectious Diseases

Volumn 7, Issue 6, 2007, Pages 395-401

  Singh, Nina ^a   Perfect, John R ^b  

^a VA Healthcare VISN 4   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; ANTIRETROVIRUS AGENT; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ASPERGILLOSIS; CLINICAL FEATURE; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCUS NEOFORMANS; GENETIC PREDISPOSITION; GRAFT REJECTION; GRAFT SURVIVAL; GRANULOMA; HELPER CELL; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNOMODULATION; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; INFLAMMATION; MYCOSIS; NEUTROPENIA; OPPORTUNISTIC INFECTION; ORGAN TRANSPLANTATION; PATHOPHYSIOLOGY; PNEUMOCYSTIS JIROVECI; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; T LYMPHOCYTE; TREATMENT FAILURE; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOLOGIC DEFICIENCY SYNDROMES; MYCOSES; OPPORTUNISTIC INFECTIONS; RECOVERY OF FUNCTION; SYNDROME; TREATMENT FAILURE;

EID: 34248525128     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(07)70085-3     Document Type: Review

References (79)

1. Casadevall A., and Pirofski L. The damage-response framework of microbial pathogenesis. Nat Rev Microbiol 1 (2003) 17-24
2. Roilides E., Dignani M., Anaissie E., and Rex J. The role of immunoreconstitution in the management of refractory opportunistic fungal infections. Med Mycol 36 (1998) 12-25
3. Blanche P., Gombert B., Ginsburg C., et al. HIV combination therapy: immune restitution causing cryptococcal lymphadenitis dramatically improved by anti-inflammatory therapy. Scand J Infect Dis 30 (1998) 615-616
4. DeSimone J., Pomerantz R., and Babinchak T. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 133 (2000) 447-454
5. French M., Price P., and Stone S. Immune restoration disease after antiretroviral therapy. AIDS 18 (2004) 1615-1627
6. Shelburne III S., Hamill R., Rodriguez-Barradas M., et al. Immune reconstitution inflammatory syndrome, emergence of a unique syndrome during highly active antiretroviral therapy. Medicine 81 (2002) 213-227
7. Singh N., Lortholary O., Alexander B., et al. An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis 40 (2005) 1756-1761
8. Cheng V., Yuen K., Wong S., et al. Immunorestitution disease in patients not infected with HIV. Eur J Clin Microbiol Infect Dis 20 (2001) 402-406
9. Einsiedel L., Gordon D., and Dyer J. Paradoxical inflammatory reaction during treatment of Cryptococcus neoformans var gattii meningitis in an HIV seronegative woman. Clin Infect Dis 39 (2004) e78-e82
10. Jenny-Avital E., and Abadi M. Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy. Clin Infect Dis 35 (2002) e128-e133
11. Skiest D. High incidence of immune reconstitution inflammatory syndrome. Contagion 2 (2005) 395-397
12. Shelburne S., and Hamill R. Risk of IRIS in patients with opportunistic infections during HAART. Contagion 2 (2005) 389-394
13. Jiang H., and Chess L. Regulation of immune responses by T cells. N Engl J Med 354 (2006) 1166-1176
14. Parkin J., and Cohen B. An overview of the immune system. Lancet 357 (2001) 1777-1789
15. Koguchi Y., and Kawakami K. Cryptococcal infection and Th1-Th2 cytokine balance. Int Rev Immunol 21 (2002) 423-438
16. Link H. The cytokine storm in multiple sclerosis. Mult Scler 4 (1998) 12-15
17. MacDonald T. T cell immunity to oral allergens. Curr Opin Infect Dis 10 (2006) 620-627
18. Pakkar N., Roos M., Danner S., and Schellekens P. Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agents. J Acquir Immune Defic Syndr Hum Retrovirol 16 (1997) 318-326
19. Kelleher A., Sewell W., and Cooper D. Effect of protease therapy on cytokine secretion by peripheral blood mononuclear cells (PBMC) from HIV-1 infected subjects. Clin Exp Immunol 115 (1999) 147-152
20. Kostense S., Raaphorst F., Notermans D., et al. Diversity of T-cell receptor BV repertoire in HIV-1 infected patients reflects the biphasic CD4+ T-cell repopulation kinetics during highly active antiretroviral therapy. AIDS 12 (1998) F235-F240
21. Lortholary O., Fontanet A., Memain N., Martin A., Sitbon K., and Dromer F. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 19 (2005) 1043-1049
22. D'Elios M., Josien R., Manghetti M., et al. Predominant Th1 cell infiltration in acute rejection episodes of human kidney grafts. Kidney Int 51 (1997) 1876-1884
23. Gras J., Cornet A., Latinne D., and Reding R. Evidence that Th1/Th2 immune deviation impacts on early graft acceptance after pediatric liver transplantation: results of immunological monitoring in 40 children. Am J Transplant 4 (2004) 444-445
24. Ferraris J., Tambutti M., Cardoni R., and Prigoshin N. Conversion from cyclosporine A to tacrolimus in pediatric kidney transplant recipients with chronic rejection: changes in the immune responses. Transplantation 77 (2004) 532-537
25. Krook H., Wennberg L., Hagberg A., Song Z., Groth C., and Korsgren O. Immunosuppressive drugs in islet xenotransplantation: a tool for gaining further insights in the mechanisms of the rejection process. Transplantation 74 (2002) 1084-1089
26. Smith K., Isbel N., Catton M., Leydon J., Becker G., and Walker R. Suppression of the humoral immune response by mycophenolate mofetil. Nephrol Dial Transplant 13 (1998) 160-164
27. Lionakis M., and Kontoyiannis D. Glucocorticoids and invasive fungal infections. Lancet 362 (2003) 1828-1838
28. Hodge S., Hodge G., Flower R., and Han P. Methyl-prednisolone upregulates monocyte IL-10 production in stimulated whole blood. Scand J Immunol 49 (1999) 548-553
29. Vecchiarelli A., Retini C., Pietrella D., et al. Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes. Infect Immun 63 (1995) 2919-2923
30. Vecchiarelli A., Retini C., Monari C., Tascini C., Bistoni F., and Kozel T. Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infect Immun 64 (1996) 2846-2849
31. Netea M., Brouwer A., Hoogendoorn E., et al. Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia: defective cytokine production and reversal by recombinant interferon-gamma therapy. Clin Infect Dis 39 (2004) e83-e87
32. Lortholary O., Dromer F., Mathoulin-Pélissier S., et al. Immune mediators in cerebrospinal fluid during cryptococcosis are influenced by meningeal involvement and human immunodeficiency virus serostatus. J Infect Dis 183 (2001) 294-302
33. Chaka W., Hyderman R., Gangaidzo I., et al. Cytokine profiles in cerebrospinal fluid of human immunodeficiency virus-infected patients with cryptococcal meningitis: no leukocytosis despite high interleukin-8 levels. J Infect Dis 176 (1997) 1633-1636
34. Singh N., Husain S., Limaye A., et al. Systemic and cerebrospinal fluid cytokine responses in organ transplant recipients with Cryptococcus neoformans infection. Transplant Immunol 16 (2006) 69-72
35. Siddiqui A., Brouwer A., Wuthiekanun V., Jaffer S., and Shattock R. IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis. J Immunol 174 (2005) 1746-1750
36. Mody C., Wood C., Syme R., and Spurrell J. The cell wall and membrane of Cryptococcus neoformans possess a mitogen for human T lymphocytes. Infect Immun 67 (1999) 936-941
37. Taborda C., and Casadevall A. Immunoglobulin M efficacy against Cryptococcus neoformans: mechanism, dose dependence, and prozone-like effects in passive protection experiments. J Immunol 166 (2001) 2100-2107
38. Tabora C., Rivera J., Zaragoza O., and Casadevall A. More is not necessarily better: prozone-like effects in passive immunization with IgG. J Immunol 170 (2003) 3621-3630
39. Jalali Z., Ng N., Singh N., and Pirofski L. Antibody response to Cryptococcus neoformans capsular polysaccharide glucoronoxylomannan in patients with solid organ transplants. Clin Vaccine Immunol 13 (2006) 740-746
40. Breton G., Adle-Biassette H., Therby A., Ramanoelina J., and Choudat L. Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. AIDS 20 (2006) 119-121
41. Koval C., Giggliotti F., Nevins D., and Demeter L. Immune reconstitution syndrome after successful treatment of Pneumocystis carinii pneumonia in a man with human immunodeficiency virus type 1 infection. Clin Infect Dis 35 (2002) 491-493
42. Sambatakou H., and Denning D. Invasive pulmonary aspergillosis transformed into fatal mucous impaction by immune reconstitution in an AIDS patient. Eur J Clin Microbiol Infect Dis 24 (2005) 628-633
43. Shelburne III S., Darcourt J., White Jr. C., et al. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis 40 (2005) 1045-1052
44. Lortholary O., Sitbon K., Dromer F., and French Cryptococcus Study Group. Evidence for HIV and Cryptococcus neoformans interactions on the pro- and antiinflamatory responses in blood during AIDS-associated cryptococcosis. Clin Microbiol Infect 11 (2005) 296-300
45. Clark D., and Croitoru K. TH1/TH2,3 imbalance due to cytokine-producing NK, gammadelta T and NK-gammadelta T cells in murine pregnancy decidua in success or failure of pregnancy. Am J Reprod Immunol 45 (2001) 257-265
46. Beeson P. Cryptococcal meningitis of nearly sixteen years' duration. Arch Intern Med 89 (1952) 797-801
47. Todeschini G., Murari C., Bonesi R., et al. Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complications. Eur J Clin Invest 29 (1999) 453-457
48. Caillot D., Couaillier J., Bernard A., et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 19 (2001) 253-259
49. Takuma T., Okada K., Uchida Y., Yamagata A., and Sawae Y. Invasive pulmonary aspergillosis resulting in respiratory failure during neutrophil recovery from postchemotherapy neutropenia in three patients with acute leukaemia. J Intern Med 252 (2002) 173-177
50. Denning D., Marinus A., Cohen J., et al. An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. J Infect 37 (1998) 173-180
51. Price P., Morahan G., Huang D., et al. Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration disease. AIDS 16 (2002) 2043-2047
52. Price P., Keane N., Stone S., Cheong K., and French M. MHC haplotypes affect the expression of opportunistic infections in HIV patients. Hum Immunol 62 (2001) 157-164
53. Mitchell D., Sorrell T., Allworth A., et al. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 20 (1995) 611-616
54. Cinti S., Armstrong W., and Kauffman C. Recurrence of increased intracranial pressure with antiretroviral therapy in an AIDS patient with cryptococcal meningitis. Mycoses 44 (2001) 497-501
55. Rambeloarisoa J., Batisse D., Thiebaut J., et al. Intramedullary abscess resulting from disseminated cryptococcosis despite immune restoration in a patient with AIDS. J Infect 44 (2002) 185-188
56. Trevenzoli M., Cattelan A., Rea F., et al. Mediastinitis due to cryptococcal infection: a new clinical entity in the HAART era. J Infect 45 (2002) 173-179
57. Co D., Hogan L., Il-Kim S., and Sandor M. T cell contributions to the different phases of granuloma formation. Immunol Lett 92 (2004) 135-142
58. Kawakami K. Regulation by innate immune T lymphocytes in the host defense against pulmonary infection with Cryptococcus neoformans. Jpn J Infect Dis 57 (2004) 137-145
59. Summers S., Dorling A., Boyle J., and Shaunak S. Cure of disseminated cryptococcal infection in a renal allograft recipient after the addition of gamma-interferon to antifungal therapy. Am J Transplant 5 (2005) 2067-2069
60. King M., Perlino C., Cinnamon J., and Jernigan J. Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviral therapy. Int J STD AIDS 13 (2002) 724-726
61. Singh N., Lortholary O., Alexander B., et al. Allograft loss in renal transplant recipients with Cryptococcus neoformans associated immune reconstitution syndrome. Transplantation 80 (2005) 1131-1133
62. Breton G., Adle-Biassette H., Therby A., et al. Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. AIDS 20 (2006) 119-121
63. Shelburne III S., Visnegarwala F., Adams C., Krause K., Hamill R., and White Jr. A. Unusual manifestations of disseminated histoplasmosis in patients responding to antiretroviral therapy. Am J Med 118 (2005) 1038-1041
64. Wislez M., Bergot E., Antoine M., Parrot A., and Carette M.-F. Acute respiratory failure following HAART introduction in patients treated for Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 164 (2001) 847-851
65. Hughes W., Feldman S., Aur R., Verzosa M., Hustu H., and Simone J. Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis. Cancer 36 (1975) 2004-2009
66. Cheng V., Yuen K., Chan W., Wong S., Ma E., and Chan R. Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis 30 (2000) 882-892
67. Lawn S., and Macallan D. Hypercalcemia: a manifestation of immune reconstitution complicating tuberculosis in an HIV-infected person. Clin Infect Dis 38 (2004) 154-155
68. Dusso A., Kamimura S., Gallieni M., et al. gamma-Inteferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses. J Clin Endocrinol Metab 82 (1997) 2222-2232
69. Blumberg H., Burman W., Chaisson R., et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Disease Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 167 (2003) 603-662
70. Razonable R., Henault M., Lee L., et al. Secretion of proinflammatory cytokines and chemokines during amphotericin B exposure is mediated by coactivation of toll-like receptors 1 and 2. Antimicrob Agents Chemother 49 (2005) 1617-1621
71. Shadkchan Y., Keisari Y., and Segal E. Cytokines in mice treated with amphotericin B-intralipid. Med Mycol 42 (2004) 123-128
72. Wheeler R., and Fink G. A drug-sensitive genetic network masks fungi from the immune system. PLoS Pathog 2 (2006) 328-339
73. Bellocchio S., Gaziano R., Bozza S., et al. Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signalling from TLR-2 to TLR-4. J Antimicrob Chemother 55 (2005) 214-222
74. Boelaert J., Goddeeris K., Ludo J., Vanopdenbosch L., and Casselman J. Relapsing meningitis caused by persistent cryptococcal antigens and immune reconstitution after the initiation of highly active antiretroviral therapy. AIDS 18 (2004) 123-124
75. Briel M., Boscacci R., Furer H., and Bucher H. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection: a meta-analysis of randomised controlled trials. BMC Infect Dis 5 (2005) 101
76. Graybill J., Sobel J., Saag M., et al. Diagnosis and management of increased intracranial pressures in patients with AIDS. Clin Infect Dis 30 (2000) 47-54
77. Hirsch H., Kaufmann G., Sendi P., and Battegay M. Immune reconstitution in HIV-infected patients. Clin Infect Dis 38 (2004) 1159-1166
78. Pappas P., Bustamante B., Ticona E., et al. Recombinant interferon-gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis. J Infect Dis 189 (2004) 2185-2191
79. Hebart H., Bollinger C., Fisch P., et al. Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individual and patients with hematologic malignancies. Blood 100 (2003) 4521-4528